Literature DB >> 16630147

Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in males.

S-H Kim1, J-M Oh, Y-S Kim, L J Palmer, C-H Suh, D-H Nahm, H-S Park.   

Abstract

BACKGROUND: Cysteinyl leukotrienes (CysLTs) play important roles in the pathogenesis of eosinophilic airway inflammation characterized by bronchoconstriction, mucus secretion and airway hyper-responsiveness via cysteinyl leukotriene receptor 1 (CysLTR1)-mediated mechanism. CysLTR1-selective antagonists have anti-bronchoconstrictive and anti-inflammatory effects in asthma, particularly aspirin-intolerant asthma (AIA).
METHODS: To investigate the association of CysLTR1 with AIA development, we identified three single nucleotide polymorphisms (SNPs), -634C>T, -475A>C, -336A>G, in the 5' upstream region of CysLTR1 gene using a direct sequencing method in 105 AIA patients, 110 ASA-tolerant asthma (ATA) patients and 125 normal healthy controls (NC).
RESULTS: Significant differences were observed in allele frequencies of the three SNPs within male subjects; Male AIA patients had higher frequencies of the minor alleles of these three SNPs than male control groups (P=0.03 for AIA vs. NC; P=0.02 for AIA vs. ATA). Moreover, three-SNP haplotype, ht2 [T-C-G], was associated with increased disease risk (odds ratio (OR)=2.71, P=0.03 for AIA vs. NC; OR=2.89, P=0.02 for AIA vs. ATA) in males. CysLTR1 haplotypes were also associated with altered gene expression; luciferase activity was significantly enhanced with the ht2 [T-C-G] construct in comparison with the ht1 [C-A-A] construct in human Jurkat cells (P=0.04).
CONCLUSION: These results suggest that genetic variants of CysLTR1 are associated with AIA in a Korean population, and may modulate CysLTR1 expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16630147     DOI: 10.1111/j.1365-2222.2006.02457.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  27 in total

1.  Association of FANCC polymorphisms with FEV1 decline in aspirin exacerbated respiratory disease.

Authors:  Jeong-Hyun Kim; Byung-Lae Park; Charisse Flerida A Pasaje; Joon Seol Bae; Jong Sook Park; Sung Woo Park; Soo-Taek Uh; Jae-Sung Choi; Yong-Hoon Kim; Mi-Kyeong Kim; Inseon S Choi; Sang Heon Cho; Byoung Whui Choi; Choon-Sik Park; Hyoung Doo Shin
Journal:  Mol Biol Rep       Date:  2011-06-14       Impact factor: 2.316

Review 2.  Genetics and pharmacogenetics of the leukotriene pathway.

Authors:  Kelan G Tantisira; Jeffrey M Drazen
Journal:  J Allergy Clin Immunol       Date:  2009-08-08       Impact factor: 10.793

3.  Genome-wide and follow-up studies identify CEP68 gene variants associated with risk of aspirin-intolerant asthma.

Authors:  Jeong-Hyun Kim; Byung-Lae Park; Hyun Sub Cheong; Joon Seol Bae; Jong Sook Park; An Soo Jang; Soo-Taek Uh; Jae-Sung Choi; Yong-Hoon Kim; Mi-Kyeong Kim; Inseon S Choi; Sang Heon Cho; Byoung Whui Choi; Choon-Sik Park; Hyoung Doo Shin
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

4.  Association of four-locus gene interaction with aspirin-intolerant asthma in Korean asthmatics.

Authors:  Seung-Hyun Kim; Hyun-Hwan Jeong; Bo-Young Cho; Myoungki Kim; Hyun-Young Lee; Jungseob Lee; Kyubum Wee; Hae-Sim Park
Journal:  J Clin Immunol       Date:  2008-04-01       Impact factor: 8.317

5.  Differential contribution of the CysLTR1 gene in patients with aspirin hypersensitivity.

Authors:  Seung-Hyun Kim; Eun-Mi Yang; Han-Jung Park; Young-Min Ye; Hyun-Young Lee; Hae-Sim Park
Journal:  J Clin Immunol       Date:  2007-07-20       Impact factor: 8.317

Review 6.  Pathogenesis of aspirin-exacerbated respiratory disease and reactions.

Authors:  Tanya M Laidlaw; Joshua A Boyce
Journal:  Immunol Allergy Clin North Am       Date:  2012-12-23       Impact factor: 3.479

Review 7.  Genetic and Epigenetic Components of Aspirin-Exacerbated Respiratory Disease.

Authors:  Amber Dahlin; Scott T Weiss
Journal:  Immunol Allergy Clin North Am       Date:  2016-11       Impact factor: 3.479

Review 8.  Pharmacogenomics of off-target adverse drug reactions.

Authors:  Sarah L Garon; Rebecca K Pavlos; Katie D White; Nancy J Brown; Cosby A Stone; Elizabeth J Phillips
Journal:  Br J Clin Pharmacol       Date:  2017-04-27       Impact factor: 4.335

9.  Variable expression of cysteinyl leukotriene type I receptor splice variants in asthmatic females with different promoter haplotypes.

Authors:  Milena Sokolowska; Karolina Wodz-Naskiewicz; Malgorzata Cieslak; Karolina Seta; Andrzej K Bednarek; Rafal Pawliczak
Journal:  BMC Immunol       Date:  2009-12-15       Impact factor: 3.615

Review 10.  Update on recent advances in the management of aspirin exacerbated respiratory disease.

Authors:  Nami Shrestha Palikhe; Joo-Hee Kim; Hae-Sim Park
Journal:  Yonsei Med J       Date:  2009-12-18       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.